Genopathy
Gene-Disorder Association · Article
Gene
JAK2
Janus Kinase 2
Manually curatedApproved treatment annotated
Association Review

In brief

The association between JAK2 (Janus Kinase 2) and Leukemia, Acute Lymphoblastic is reported, with clinical genetic testing available.

Sources 1
Clinical variants 0
Symptoms 5
Compounds 2
Trials 107of 816 via JAK2 compounds
Publications 10
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
JAK2

The gene

3 source summaries

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Leukemia, Acute Lymphoblastic

The disorder

21 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Phenotype

Clinical features

1 clinical feature

The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.

Request access
06
Population genetics

GWAS signals

1 GWAS phenotype

Gene-associated GWAS phenotypes matching the disorder, with best SNP, score, risk-allele frequency and effect size.

Request access
07
Interventions

Therapeutics

2 compounds & drugs

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

Request access
08
Human studies

Clinical trials

816 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.

Request access
09
Literature

Reading

10 publications

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
10
Provenance

References & sources

17 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access